Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

ACTIVE NOT RECRUITING

Orbital Fractures Registry

NCT03887988 · View on ClinicalTrials.gov ↗

Study Summary

Approximately 300 patients presenting orbital blow-out fracture will be enrolled prospectively in this registry. All patients, surgically and nonsurgically treated as per standard (routine) of care will be followed-up (FU) within the registry for a period of 6 months.

Interventions

  • PROCEDURE Primary "early" reconstruction
  • OTHER Nonsurgical
  • PROCEDURE Primary "delayed" reconstruction
  • PROCEDURE Secondary reconstruction

Study Locations (14)

Other

  • Medical Center Hamburg Eppendorf — Hamburg
  • Klinikum der LMU München — Munich
  • Eramus MC — Rotterdam
  • Mayo Hospital — Lahore
  • Hamad Medical Corporation — Doha
  • Emergency Clinical County Hospital of Constanta — Constanța
  • Federal State Budgetary Institution "National Medical and Surgical Center named after N.I. Pirogov" of the Ministry of Healthcare of the Russian Federation — Moscow
  • Clinic for Maxillofacial Surgery, University of Belgrade — Belgrade
  • King Edward VIII Hospital — Durban
  • Uppsala University Hospital — Uppsala
  • Universitaetsspital Basel — Basel

California

  • UC Davis — Sacramento

Catalonia

  • Hospital Vall d' Hebron — Barcelona

Madrid

  • 12 de Octubre University Hospital — Madrid

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2019-11-01
Est. Completion 2026-03

Sponsor

AO Innovation Translation Center

13 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03887988

The ClinicalTrials.gov registry entry for NCT03887988 describes a study currently listed as active not recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AO Innovation Translation Center, which has 13 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 2 conditions, with Orbital Fractures appearing as the primary indexed condition, and to 4 interventions — of which Primary "early" reconstruction is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT03887988 reports 14 study locations spanning 4 distinct geographic areas — top geographies include Other, California, Catalonia. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT03887988 about?

NCT03887988 is a clinical study titled "Orbital Fractures Registry". Approximately 300 patients presenting orbital blow-out fracture will be enrolled prospectively in this registry. All patients, surgically and nonsurgically treated as per standard (routine) of care will be followed-up (FU) within the registry for a period of 6 months.

What is the current status of trial NCT03887988?

This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2019-11-01. Estimated completion is 2026-03.

What conditions does trial NCT03887988 study?

This clinical trial studies the following conditions: Orbital Fractures, Blow Out Fracture of Orbit. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT03887988?

The interventions under investigation include: Primary "early" reconstruction (PROCEDURE), Nonsurgical (OTHER), Primary "delayed" reconstruction (PROCEDURE), Secondary reconstruction (PROCEDURE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT03887988?

This trial is sponsored by AO Innovation Translation Center, which has 13 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT03887988 being conducted?

This trial has 14 study locations across California, Catalonia, Madrid. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial